Details for New Drug Application (NDA): 009357
✉ Email this page to a colleague
NDA 009357 describes RAU-SED, which is a drug marketed by Bristol Myers Squibb and is included in one NDA. Additional details are available on the RAU-SED profile page.
The generic ingredient in RAU-SED is reserpine. There are nineteen drug master file entries for this compound. Additional details are available on the reserpine profile page.
The generic ingredient in RAU-SED is reserpine. There are nineteen drug master file entries for this compound. Additional details are available on the reserpine profile page.
Summary for 009357
| Tradename: | RAU-SED |
| Applicant: | Bristol Myers Squibb |
| Ingredient: | reserpine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 009357
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.1MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.25MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 006
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
